Endocrine cells and lysozyme immunoreactivity in the gallbladder

Area of Science:

• Gastroenterology and Hepatology
• Surgical Pathology
• Oncogenesis

Background:

• Metaplastic changes in the gallbladder mucosa are not well understood.
• Identifying precursors to gallbladder adenocarcinoma is crucial for early detection and treatment.
• Gastrointestinal metaplasia may play a role in gallbladder carcinogenesis.

Purpose of the Study:

• To investigate the prevalence and types of metaplastic changes in human gallbladders.
• To determine if lysozyme immunoreactivity and/or endocrine cells serve as markers for gallbladder metaplasia.
• To assess the potential link between metaplastic changes and the development of gallbladder adenocarcinoma.

Main Methods:

• Histological and immunohistochemical examination of 89 gallbladders.
• Detection of metaplastic changes, including mucous gland metaplasia, Paneth's cells, and goblet cells.
• Assessment of lysozyme immunoreactivity and argyrophilic (endocrine) cells.

Main Results:

• Metaplastic changes were observed in 32 cases of chronic cholecystitis.
• Lysozyme immunoreactivity and/or endocrine cells were identified as markers for gastrointestinal metaplasia.
• At least half of gallbladder adenocarcinomas (51.0%) exhibited markers of metaplasia, suggesting a common origin.

Conclusions:

• Lysozyme and endocrine cells are reliable markers for gastrointestinal metaplasia in the gallbladder.
• A significant proportion of gallbladder adenocarcinomas may arise from metaplastic changes.
• Further research into metaplasia as a precursor to gallbladder cancer is warranted.